Year |
Citation |
Score |
2020 |
Mata DA, Yang SR, Ferguson DC, Liu Y, Sharma R, Benhamida JK, Al-Ahmadie HA, Chakravarty D, Solit DB, Tickoo SK, Gupta S, Arcila ME, Ladanyi M, Feldman DR, Reuter VE, et al. RAS/MAPK Pathway Driver Alterations Are Significantly Associated with Oncogenic KIT Mutations in Germ-cell Tumors. Urology. PMID 32721511 DOI: 10.1016/J.Urology.2020.07.027 |
0.308 |
|
2020 |
Gupta S, Vanderbilt CM, Leibovich BC, Herrera-Hernandez L, Raghunathan A, Sukov WR, Voss JS, Barr Fritcher EG, Reed KA, Lohse CM, Reuter VE, Jimenez RE, Thompson RH, Cheville JC. Secondary Renal Neoplasia Following Chemotherapy or Radiation in Pediatric Patients. Human Pathology. PMID 32681944 DOI: 10.1016/J.Humpath.2020.07.014 |
0.356 |
|
2020 |
Marcon J, DiNatale RG, Sanchez A, Kotecha RR, Gupta S, Kuo F, Makarov V, Sandhu A, Mano R, Silagy AW, Blum KA, Nassau DE, Benfante NE, Ortiz MV, Carlo MI, et al. Comprehensive genomic analysis of translocation renal cell carcinoma reveals copy number variations as drivers of disease progression. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 32220885 DOI: 10.1158/1078-0432.Ccr-19-3283 |
0.362 |
|
2020 |
Gupta S, Inwards CY, Van Dyke DL, Jimenez RE, Cheville JC. Defining Clear Cell Papillary Renal Cell Carcinoma in Routine Clinical Practice. Histopathology. PMID 31989679 DOI: 10.1111/His.14071 |
0.307 |
|
2019 |
Gupta S, Argani P, Jungbluth AA, Chen YB, Tickoo SK, Fine SW, Gopalan A, Al-Ahmadie HA, Sirintrapun SJ, Sanchez A, Hakimi AA, Mcfarlane T, Salazar PA, Williamson SR, Skala SL, et al. TFEB Expression Profiling in Renal Cell Carcinomas: Clinicopathologic Correlations. The American Journal of Surgical Pathology. 43: 1445-1461. PMID 31600176 DOI: 10.1097/Pas.0000000000001307 |
0.332 |
|
2019 |
Gupta S, Swanson AA, Chen YB, Lopez T, Milosevic D, Kipp BR, Leibovich BC, Thompson RH, Herrera-Hernandez L, Cheville JC, Jimenez RE. Incidence of Succinate Dehydrogenase and Fumarate Hydratase-Deficient Renal Cell Carcinoma Based on Immunohistochemical Screening with SDHA/SDHB and FH/2SC. Human Pathology. PMID 31299266 DOI: 10.1016/J.Humpath.2019.07.004 |
0.376 |
|
2019 |
Walasek A, Gupta S, Fine S, Russo P. Juxtaglomerular Cell Tumor: A Rare, Curable Cause of Hypertension in a Young Patient. Urology. PMID 31233811 DOI: 10.1016/J.Urology.2019.06.009 |
0.326 |
|
2019 |
Hau AM, Gupta S, Leivo MZ, Nakashima K, Macias J, Zhou W, Hodge A, Wulfkuhle J, Conkright B, Bhuvaneshwar K, Rao S, Madhavan S, Petricoin EF, Hansel DE. Dynamic Regulation of Caveolin-1 Phosphorylation and Caveolae Formation by mTORC2 in Bladder Cancer Cells. The American Journal of Pathology. PMID 31199921 DOI: 10.1016/J.Ajpath.2019.05.010 |
0.302 |
|
2019 |
Gupta S, Sosa CP, Kosari F, Folpe A, Bhinge KN, Yang L, Agahi A, Johnson SH, Frank I, Boorjian SA, Hansel DE, Al-Ahmadie HA, Reuter VE, Vasmatzis G, Jimenez RE, et al. A comparison of adult rhabdomyosarcoma and high grade neuroendocrine carcinoma of the urinary bladder reveals novel PPP1R12A fusions in rhabdomyosarcoma. Human Pathology. PMID 30946934 DOI: 10.1016/J.Humpath.2019.03.007 |
0.334 |
|
2019 |
Blum K, DiNatale R, Sanchez A, Silagy A, Marcon J, Mano R, Gupta S, Tickoo S, Reuter V, Coleman J, Russo P, Hakimi AA. Mp42-14 Sarcomatoid Features In Renal Cell Carcinoma: Rethinking The Stage-Survival Paradigm The Journal of Urology. 201. DOI: 10.1097/01.Ju.0000556217.19668.90 |
0.342 |
|
2019 |
Marcon J, Sanchez A, Gupta S, Natale RGD, Sandhu A, Mano R, Silagy AW, Blum KA, Nassau DE, Motzer RJ, Coleman JA, Russo P, Reuter VE, Hakimi AA, Reznik E. Mp16-15 Comprehensive Analysis Of Oncogenic Events In Translocation Renal Cell Carcinoma The Journal of Urology. 201. DOI: 10.1097/01.Ju.0000555351.44300.3F |
0.331 |
|
2019 |
Marcon J, Sanchez A, Gupta S, Di Natale R, Sandhu A, Mano R, Silagy A, Blum K, Nassau D, Motzer R, Coleman J, Russo P, Reuter V, Hakimi A, Reznik E. Comprehensive investigation of the molecular underpinnings of translocation renal cell carcinoma European Urology Supplements. 18: e78-e79. DOI: 10.1016/S1569-9056(19)30060-0 |
0.336 |
|
2018 |
Gupta S, Sahu D, Bomalaski JS, Frank I, Boorjian SA, Thapa P, Cheville JC, Hansel DE. Argininosuccinate Synthetase-1 (ASS1) Loss in High-Grade Neuroendocrine Carcinomas of the Urinary Bladder: Implications for Targeted Therapy with ADI-PEG 20. Endocrine Pathology. PMID 29453600 DOI: 10.1007/S12022-018-9516-9 |
0.337 |
|
2018 |
Nassau DE, Sanchez A, Dinatale R, Blum KA, Ghanaat M, Gupta S, Arcila ME, Voss MH, Motzer RJ, Russo P, Coleman J, Reznik E, Reuter V, Hakimi AA. MP28-08 CLINICOPATHOLOGIC AND GENOMIC EVALUATION OF TRANSLOCATION RENAL CELL CARCINOMA Journal of Urology. 199. DOI: 10.1016/J.Juro.2018.02.908 |
0.32 |
|
2017 |
Gupta S, Zhang J, Erickson LA. Composite Pheochromocytoma/Paraganglioma-Ganglioneuroma: A Clinicopathologic Study of Eight Cases with Analysis of Succinate Dehydrogenase. Endocrine Pathology. PMID 28752484 DOI: 10.1007/S12022-017-9494-3 |
0.307 |
|
2017 |
Gupta S, Zhang J, Milosevic D, Mills JR, Grebe SK, Smith SC, Erickson LA. Primary Renal Paragangliomas and Renal Neoplasia Associated with Pheochromocytoma/Paraganglioma: Analysis of von Hippel-Lindau (VHL), Succinate Dehydrogenase (SDHX) and Transmembrane Protein 127 (TMEM127). Endocrine Pathology. PMID 28646318 DOI: 10.1007/S12022-017-9489-0 |
0.338 |
|
2017 |
Gupta S, Johnson SH, Vasmatzis G, Porath B, Rustin JG, Rao P, Costello BA, Leibovich BC, Thompson RH, Cheville JC, Sukov WR. TFEB-VEGFA (6p21.1) co-amplified renal cell carcinoma: a distinct entity with potential implications for clinical management. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. PMID 28338654 DOI: 10.1038/Modpathol.2017.24 |
0.372 |
|
2016 |
Sahu D, Gupta S, Hau AM, Nakashima K, Leivo MZ, Searles SC, Elson P, Bomalaski JS, Casteel DE, Boss GR, Hansel DE. Argininosuccinate Synthetase 1 Loss in Invasive Bladder Cancer Regulates Survival through General Control Nonderepressible 2 Kinase-Mediated Eukaryotic Initiation Factor 2α Activity and Is Targetable by Pegylated Arginine Deiminase. The American Journal of Pathology. PMID 27979310 DOI: 10.1016/J.Ajpath.2016.09.004 |
0.38 |
|
2016 |
Gupta S, Jimenez RE, Folpe AL, Cheville JC. Renal Leiomyoma and Leiomyosarcoma: A Study of 57 Cases. The American Journal of Surgical Pathology. PMID 27276240 DOI: 10.1097/Pas.0000000000000681 |
0.337 |
|
2016 |
Gupta S, Zhang J, Rivera M, Erickson LA. Urinary Bladder Paragangliomas: Analysis of Succinate Dehydrogenase and Outcome. Endocrine Pathology. PMID 27262318 DOI: 10.1007/S12022-016-9439-2 |
0.317 |
|
2016 |
Sanfrancesco J, McKenney JK, Leivo MZ, Gupta S, Elson P, Hansel DE. Sarcomatoid Urothelial Carcinoma of the Bladder: Analysis of 28 Cases With Emphasis on Clinicopathologic Features and Markers of Epithelial-to-Mesenchymal Transition. Archives of Pathology & Laboratory Medicine. PMID 27031776 DOI: 10.5858/Arpa.2015-0085-Oa |
0.308 |
|
2016 |
Gupta S, Hau AM, Al-Ahmadie HA, Harwalkar J, Shoskes AC, Elson P, Beach JR, Hussey GS, Schiemann WP, Egelhoff TT, Howe PH, Hansel DE. Transforming Growth Factor-β Is an Upstream Regulator of Mammalian Target of Rapamycin Complex 2-Dependent Bladder Cancer Cell Migration and Invasion. The American Journal of Pathology. PMID 26988652 DOI: 10.1016/J.Ajpath.2016.01.008 |
0.307 |
|
2015 |
Gupta S, Naini BV, Munoz R, Graham RP, Kipp BR, Torbenson MS, Mounajjed T. Hepatocellular Neoplasms Arising in Association With Androgen Use. The American Journal of Surgical Pathology. PMID 26685086 DOI: 10.1097/Pas.0000000000000576 |
0.309 |
|
2015 |
Gupta S, Thompson RH, Boorjian SA, Thapa P, Hernandez LP, Jimenez RE, Costello BA, Frank I, Cheville JC. High grade neuroendocrine carcinoma of the urinary bladder treated by radical cystectomy: a series of small cell, mixed neuroendocrine and large cell neuroendocrine carcinoma. Pathology. 47: 533-42. PMID 26308137 DOI: 10.1097/Pat.0000000000000301 |
0.359 |
|
2015 |
Lohse CM, Gupta S, Cheville JC. Outcome prediction for patients with renal cell carcinoma. Seminars in Diagnostic Pathology. 32: 172-83. PMID 25753528 DOI: 10.1053/J.Semdp.2015.02.008 |
0.367 |
|
2015 |
Sahu D, Gupta S, Hau AM, Elson P, Bomalaski J, Boss GR, Hansel DE. Abstract 4712: Targeting the arginine-nitric oxide pathway to arrest development and progression of invasive bladder cancer Cancer Research. 75: 4712-4712. DOI: 10.1158/1538-7445.Am2015-4712 |
0.343 |
|
2013 |
Gupta S, Hau AM, Beach JR, Harwalker J, Mantuano E, Gonias SL, Egelhoff TT, Hansel DE. Mammalian target of rapamycin complex 2 (mTORC2) is a critical determinant of bladder cancer invasion. Plos One. 8: e81081. PMID 24312263 DOI: 10.1371/Journal.Pone.0081081 |
0.316 |
|
2013 |
Gupta S, Maria M, Bomalaski J, Elson PJ, Singh K, Harwalkar J, Carver P, Almasan A, Hansel DE. Abstract 11: Arginine deprivation therapy using ADI-PEG20 as a novel therapeutic modality in the treatment of bladder cancer. Cancer Research. 73: 11-11. DOI: 10.1158/1538-7445.Am2013-11 |
0.369 |
|
2012 |
Gupta S, Bomalaski JS, Carver PD, Hansel DE. Abstract 3652: Pegylated arginine deiminase (ADI-PEG20) as a potential therapeutic agent for rarer variants of bladder cancer that are deficient for argininosuccinate synthetase Cancer Research. 72: 3652-3652. DOI: 10.1158/1538-7445.Am2012-3652 |
0.369 |
|
2011 |
Xu X, Gupta S, Hu W, McGrath BC, Cavener DR. Hyperthermia induces the ER stress pathway. Plos One. 6: e23740. PMID 21876766 DOI: 10.1371/Journal.Pone.0023740 |
0.602 |
|
2010 |
Cavener DR, Gupta S, McGrath BC. PERK in beta cell biology and insulin biogenesis. Trends in Endocrinology and Metabolism: Tem. 21: 714-21. PMID 20850340 DOI: 10.1016/J.Tem.2010.08.005 |
0.61 |
|
2010 |
Gupta S, McGrath B, Cavener DR. PERK (EIF2AK3) regulates proinsulin trafficking and quality control in the secretory pathway. Diabetes. 59: 1937-47. PMID 20530744 DOI: 10.2337/Db09-1064 |
0.605 |
|
2009 |
Gupta S, McGrath B, Cavener DR. PERK regulates the proliferation and development of insulin-secreting beta-cell tumors in the endocrine pancreas of mice. Plos One. 4: e8008. PMID 19956728 DOI: 10.1371/Journal.Pone.0008008 |
0.615 |
|
2009 |
Feng D, Wei J, Gupta S, McGrath BC, Cavener DR. Acute ablation of PERK results in ER dysfunctions followed by reduced insulin secretion and cell proliferation. Bmc Cell Biology. 10: 61. PMID 19732428 DOI: 10.1186/1471-2121-10-61 |
0.615 |
|
2009 |
Gupta S, McGrath B, Cavener DR. Correction: PERK Regulates the Proliferation and Development of Insulin-Secreting Beta-Cell Tumors in the Endocrine Pancreas of Mice Plos One. 4. DOI: 10.1371/annotation/b22a2657-7ce6-471a-8593-8bc8e86e2efa |
0.581 |
|
Show low-probability matches. |